Materials and Methods
Animals. B10 nu/nu female mice were obtained from the Small Animal Section, NIH, Bethesda, MD . C57BL/6 (B6), B10, B10.BR, and DBA/2 mice were obtained from The Jackson Laboratory, Bar Harbor, ME . B6 .PL-Thy-la (B6-Thy-1 .1) mice (20) were a generous gift of Dr . John Wunderlich from the Frederick Cancer Research Facility, Frederick, MD . B6 .CH-2 6m' (bml) (21) , B6 .CH-26'" 12 (bm12) (22) , B6 .CH-2 6-6 (bm6) (23) , (bm6 x bm12)F,, and B6 .Tlaa mice (24) were bred in our own animal facility . B10 nude mice were 6-14 wk old at the time of engraftment and adoptive transfer . B6 mice were 13-16 wk old at the time of engraftment. The MHC haplotypes of the various strains are listed in Table 1 .
Monoclonal Antibodies . Anti-L3T4 mAb was either a culture supernatant of the hybridoma cell line GK 1 .5 (25) , generously provided by Dr. Frank Fitch, University of Chicago, Chicago, IL, or an ascitic fluid of the hybridoma cell line RL-172/4 (26) , generously provided by Dr . Ada Kruisbeek, NIH. Anti-Lyt-2 .2 mAb was a culture supernatant of the hybridoma cell line 83-12-5, generously provided by Dr . Jeffrey Bluestone, NIH.
Isolation of T Cell Subpopulations. Depletion of L3T4+ T cells or Lyt-2+ T cells was accomplished by incubating spleen cells at a density of 10 7 cells/ml with anti-L3T4 (1 :2 dilution of GK1 .5 or a 1 :100 dilution of RL-172/4) or anti-Lyt-2 .2 (1 :5 dilution) mAbs for 30 min at 37'C . Cells were then pelleted, resuspended in C, and incubated for 50 min at 37°C . The cells treated with GK1 .5 were resuspended at 10 7/ml in rabbit complement (Cedar Lane Laboratories Ltd., Ontario, Canada) diluted 1:10. The cells treated with RL-172/4 and 83-12-5 were resuspended at 10 8/ml in Guinea pig complement (Gibco Laboratories, Grand Island, NY) diluted 1 :3 . Treated cells were washed three times before injection into experimental animals. To avoid the confusion of referring to T cell populations in negative terms, anti-Lyt-2 plus C-treated spleen cells will be referred to as L3T4 + T cells and anti-L3T4 plus C-treated spleen cells will be referred to as Lyt-2+ T cells.
Skin Grafting of Normal B6 Mice . B6 mice were engrafted either on the left flank or on both flanks with tailskin grafts according to an adaptation of the method of Billingham and Medawar (27) . Bandages were removed on day 7 and the grafts were scored daily until rejection (defined as loss of >80% of the grafted tissue) or the end point of the experiment .
Skin Grafting and Adoptive Transfer. Female B10 nude mice were engrafted on the thorax on day 0 with tailskin allografts from donor mice according to an adaptation of the method of Billingham and Medawar (27) . On day 1, the mice were injected intravenously with 5-7 x 107 spleen cells from unprimed B6 mice or B6 Thy-1 .1 congenic mice that had been (a) untreated, (b) treated with anti-L3T4 plus C in vitro, or (c) treated with anti-Lyt-2 .2 plus C in vitro according to the above procedures . Bandages were removed on day 7 and the grafts were scored daily until rejection (defined as loss of >80% of the grafted tissue) or the end point of the experiment. Reagents Used for Flow Cytometry (FCM). Anti-Fc receptor mAb (2.4G2) (28) and biotinconjugated monoclonal anti-L3T4 (GK1 .5) (25) were generous gifts from J. Titus (Immunology Branch, National Cancer Institute). FITC anti-Thy-1 .2 (clone 30-H12), FITCanti-Leu-1, biotin-conjugated anti-Lyt-2 (clone , and biotin-conjugated anti-Leu-1 were purchased from Becton Dickinson Immunocytometry Systems (Mountain View, CA) . Texas Red (TR)-Streptavidin was purchased from Bethesda Research Laboratories, Bethesda, MD. Anti-Fc receptor antibody (2.4G2) was used to block Fc receptor-mediated antibody binding during the staining procedures.
Flow Cytometry Analysis. Multicolor FCM was performed as previously described (29) using a modified FAGS II (Becton Dickinson Immunocytometry Systems) equipped with (a) the manufacturer's filters and photomultiplier tubes, (b) argon ion laser for FITC excitation (488 nm), (c) pumped dye (rhodamine 6G) laser for TR excitation (590 nm), and it was interfaced to a Digital Equipment Corp. (Marlboro, MA) PDP 11/2423 (30) . Fluorescence data were collected using logarithmic amplification on 50,000 viable cells as determined by forward light scatter intensity and propidium iodide exclusion . Logarithmic amplification was provided by a three-decade logarithmic amplifier constructed from an NIH-modified design of R. Hiebert, LASL (Los Alamos Scientific Laboratories, Los Alamos, NM). One-color fluorescence data were displayed as cell frequency histograms or immunofluorescence profiles in which log fluorescence intensity was plotted in 1,024 channels on the x-axis and cell number shown on the y-axis . Two-color immunofluorescence data were displayed as contour diagrams in which log intensities of green (FITC) fluorescence were plotted in 64 channels on the x-axis and the log intensities of red (TR) fluorescence were plotted on the y-axis . Constant values of the percentage of total cell number on the z-axis were selected to draw the rings or contours around peaks of cells correlating FITC and TR fluorescence .
Results
Experimental Model. To assess the T cell subpopulations involved in skin allograft rejection, we used an adoptive transfer model in which H-2b nude mice were engrafted on day 0 with tailskin allografts and reconstituted on day 1 with 50-70 x 106 syngeneic H-2 b spleen cell subpopulations . To determine if skin allograft rejection in this model depended upon reconstitution with immunocompetent T cells, B10 nude mice engrafted with B10 .BR (H-2') skin were reconstituted with unfractionated spleen cells from either normal B 10 or T cell-deficient nude 1310 mice . As can be seen in Fig . 1 , nude mice given normal B10 spleen cells rejected their skin allografts rapidly whereas nude mice given T cell deficient B10 spleen cells failed to do so . Unreconstituted nude mice also failed to reject the skin allografts (data not shown) . These data indicated that the ability to reject skin allografts in this model was contingent upon the adoptive transfer of immunocompetent T cells.
Skin Allograft Rejection by Negatively Selected Populations ofPhenotypically Distinct
T Cells. We next tested the ability of phenotypically distinct T cell subpopulations to induce graft rejection . B10 nude mice engrafted with fully allogeneic DBA/2 skin grafts were reconstituted with H-2b spleen cells that were (a) untreated, (b) treated with anti-L3T4 plus C, generating a T cell population that was overwhelmingly Lyt-2' (<I% of the remaining T cells were L3T4''), or (c) treated with anti-Lyt-2 plus C, generating a T cell population that was overwhelmingly L3T4' (<I% of the remaining T cells were Lyt-2+ confusion of referring to T cell populations in negative terms, anti-Lyt-2 plus C-treated spleen cells are referred to as L3T4' T cells and anti-L3T4 plus Ctreated spleen cells are referred to as Lyt-2' T cells. As can be seen in Fig. 2 , all three H-26 T cell populations effected the rapid rejection of DBA/2 skin allografts . In contrast to their rejection of allogeneic grafts, reconstituted nude mice failed to reject syngeneic B6 skin grafts (data not shown) . These results indicated that negatively selected populations of L3T4' and Lyt-2' T cells were each able to mediate skin allograft rejection. However, it was possible that cells of the reciprocal phenotype derived from either the nude host or from residual cells in the donor innoculum contributed to the rejection of skin allografts in this adoptive transfer model. To assess the possibility that cells derived from the nude host contributed to skin allograft rejection, we performed an experiment in which donor H-2b spleen cells were from B6-Thy-1 .1 congenic mice . Since mature T cells of B10 nude host origin would be Thy-1 .2', they would be discernible from T cells derived from the Thy-1 .1 donor innoculum. Accordingly, B6-Thy-1 .1 spleen cell populations were injected into B10 nude mice that had been engrafted with fully allogeneic DBA/2 skin grafts to provide maximal stimulation for the expansion of small numbers of host-derived T cells. Further, the mice were reconstituted with isolated T cell populations as well as unseparated T cell populations in the event that reconstitution with unfractionated T cell populations suppressed the Table 11 that while rare cells expressing Thy-1 .2 were present in unreconstituted nude mice, they were overwhelmingly L3T4 -,Lyt-2 -. This contrasted markedly with spleen cells from either B 10 normal mice (Fig. 3 b) or B 10 nude mice reconstituted with Thy-1 .2+ spleen cells (Fig. 3c) . In these latter animals 18-20% of spleen cells were positive for both Thy-1 .2 and L3T4/Lyt-2. Spleens of nude mice reconstituted with either unfractionated or isolated Thy-1 .1 congenic spleen cells contained significant numbers of Thy-1 .2-cells expressing L3T4/Lyt2, but Thy1 .2+ cells expressing L3T4/Lyt2 were virtually undetectable (<0.5%) (Fig. 3 , df, and Table II) . We assessed the same parameters on days 42 and 76 and observed identical results (data not shown) . Thus, at least over the time period necessary for most skin graft experiments, there was no evidence indicating the appearance of mature T cells of nude host origin in the spleens of the adoptively transferred mice .
To assess the alternative possibility, that significant in vivo expansion of contaminating T cells from the donor spleen cell innoculum occurs, B10 nude tions. It was clear from the experiment shown in Fig. 2 that each phenotypically distinct T cell population could effect the rejection of fully allogeneic skin grafts . To more precisely identify the antigen specificities triggering allograft rejection responses by each isolated T cell phenotype, we engrafted B10 nude mice with (a) MHC class I-disparate bml skin grafts, (b) MHC class II-disparate bm12 skin grafts, or (c) multiple minor H-disparate BALB.B skin grafts and we reconstituted them with unfractionated or isolated H-2b T cell populations. As can be seen in Fig. 5 (left), unfractionated T cell populations containing both L3T4 + and Lyt-2+ T cell populations effected the rapid rejection of MHC class I, MHC class II, and multiple minor H disparate grafts . As can be seen in Fig. 5 (middle), the isolated L3T4 + T cell population effected the rapid rejection of MHC class II and minor H disparate grafts, but did not effect the rapid rejection of MHC class I disparate grafts . Indeed, B10 nude mice reconstituted with isolated L3T4 + T cells retained MHC class I-disparate bml skin allografts indefinitely (>300 d). In contrast, it can be seen in Fig. 5 (right) that the isolated Lyt-2+ T cell population did effect the rapid rejection of MHC class I-disparate grafts, but did not effect the rapid rejection of MHC class II-or minor Hdisparate grafts . It might be noted that the reciprocal abilities of isolated L3T4 + and Lyt-2' T cell populations to effect the rejection of MHC class II-and class I-disparate skin grafts, respectively, but not vice versa, further support the conclusion that, in this experimental model, T cells of the inappropriate phenotype from either the nude host or the donor inocula do not expand to sufficient numbers to significantly influence the experimental outcome. Thus, this experiment demonstrates that isolated populations of L3T4 + and Lyt-2+ T cells can anti-L3T4 + C' FIGURE 4. Failure to detect in vivo expansion of contaminating T cells after adoptive transfer . B10 nude mice were engrafted on day 0 with allogeneic skin grafts, and were reconstituted on day 1 with 50 X 106 B6 spleen cells that were untreated, treated with antiLyt-2 plus C, or treated with anti-L3T4 plus C. Before injection, these cell populations were analyzed by FCM, and it was found that the cells of the untreated donor inoculum were 18% L3T4 + and 11 % Lyt-2+; the cells of the anti-Lyt-2 plus C-treated donor inoculum were 16.6% L3T4 * and <1% Lyt-2+; and the cells of the anti-L3T4 plus C-treated donor inoculum were <1% L3T4 + and 10% Lyt-2+. 30 d after reconstitution, the phenotypes of the spleen cells of mice from each group were assayed by FCM. Solid lines represent staining with either fluoresceinated anti-L3T4 or anti-Lyt-2 mAbs . Dotted lines represent control staining with fluoresceinated anti-Leu-1 mAb. Intensity levels for curve integration were chosen as the intersection of profiles for positive (-) and negative (---) antibodies reacted with spleen cells from animals that received untreated cells. Percentages of positive cells were determined as the difference above these levels between positive cells incubated with the experimental antibody and positive cells incubated with the control antibody .
each individually effect allograft rejection, but only in response to specific and different alloantigens . This observation indicates that within each phenotypically distinct T cell subpopulation are cells with the appropriate specificity and the requisite functional abilities to mediate the rejection process. Interestingly, Lyt-2+ T cell populations, which rejected class I-disparate grafts, are known from in vitro studies to possess both lymphokine-secreting Th cells and lymphokine-responsive Tk cells specific for class I alloantigens (9, 15, 16, 19, 31) , and L3T4 + T cell populations, which rejected MHC class II-and multiple minor H-disparate grafts, are similarly known to possess both lymphokine-secreting Th cells and lymphokine-responsive Tk cells specific for these alloantigens (13, 14, 17, 19, 31) . Lyt-2+ T cell populations that failed to rapidly reject MHC class 11-and minor H-disparate grafts contain Tk cells (13, 14, 19, (32) (33) (34) 5 . Reconstituting spleen cell populations . Specificity of skin allograft rejection by phenotypically distinct T cell populations . B10 nude mice were engrafted on day 0 with bra l, bm12, or BALB .B skin grafts, and were reconstituted on day 1 with 50 x 106 B10 spleen cells that were unfractionated (left), L3T4' by negative selection with anti-Lyt-2 plus C (center), or Lyt-2' by negative selection with anti-L3T4 plus C (right) . Number of mice in each group is indicated. Grafts were scored daily until rejection or day 60 . Control, reconstituted mice retained syngeneic B6 skin grafts indefinitely .
preparation) specific for these alloantigens ; and L3T4 + T cell populations that failed to rapidly reject M HC class 1-disparate grafts contain Th cells (15, 19, 31, (35) (36) (37) but lack Tk cells (14, 17, 19) specific for MHC class I alloantigens . Thus, in Fig. 5 , it appears that isolated Lyt-2+ and L3T4+ T cell populations rejected only those skin allografts for which they contained both Th and Tk cells. With regard to minor H-specific T cell populations, we have consistently failed to detect minor H-specific Lyt-2+ T cells that either secrete lymphokine or provide help for in vitro CTL responses, despite numerous and intense efforts involving multiply immunized and skin engrafted animals (Mizuochi, T ., A. S. Rosenberg, and A. Singer, manuscript in preparation) . However, Lyt-2+ proliferative cytolytic T cell clones specific for the minor locus H-1 have been reported (38) , although it is unclear whether H-1 is unique among minor H loci . Nevertheless, it is conceivable that minor H-specific Lyt-2+ Th cells are present in frequencies that have escaped our detection but that are responsible for the slow rejection of minor H-disparate BALB .B skin allografts in some of the experimental mice (Fig . 5, right) . Skin Allograft Rejection Resultingfrom Interactions Between Phenotypically Distinct T Cell Subsets. To directly test the implication that both inducer and effector T cell functions are required to initiate and mediate skin allograft rejection, we turned to a system in which Th and Tk in vitro functions are mediated by phenotypically distinct T cell populations and so are readily separable (32, 33, 39, 40) Host -B104 nude Graft -B6d FIGURE 6 . Interactions between phenotypically distinct T cell populations in the rejection of H-Y-disparate skin allografts . (A) Female B10 nude mice were engrafted with B6 male tail skin grafts on day 0 and the following day were reconstituted with 70 X 106 female B6 spleen cells that were untreated, L3T4' by negative selection with anti-Lyt-2 plus C, or Lyt-2' by negative selection with anti-L3T4 plus C. (B) Female B10 nude mice were engrafted with B6 male tail skin grafts on day 0 and the following day were reconstituted with 70 X 106 unfractionated or fractionated female B6 spleen cells. Mice reconstituted with both L3T4' and Lyt-2' spleen cell populations received 35 X 10 6 of each . (C) Female B10 nude mice were engrafted with B6 male tail skin grafts on day 0 and the following day were reconstituted with 50 X 106 female B6 spleen cells that were L3T4' by negative selection with anti-Lyt-2 plus C. On day 60, the mice were injected with an additional 50 X 106 female B6 spleen cells that were Lyt-2' by negative selection with anti-L3T4 plus C. Grafts were scored daily until rejection or the end of each experiment . Number of mice in each group is indicated. Control, reconstituted mice retained B6 female skin grafts indefinitely. tailskin grafts and reconstituted them with H-2b female spleen cell subpopulations. Fig. 6a reveals the results of our initial studies: neither isolated L3T4 + nor Lyt-2+ T cell populations effected the rejection of H-Y disparate skin grafts, whereas the untreated T cell population that contained both L3T4 + and Lyt-2+ T cells did effect the rejection of these grafts . To more formally test the need for T cells of both phenotypes to effect the rejection of H-Y disparate grafts, we engrafted H-2b female nude mice with B6 male skin and reconstituted them with untreated, L3T4+,Lyt-2+ , or a mixture of T cell populations from female H-2b mice (Fig . 66) . Total cell number was kept constant among the groups . In Fig.  6 b it is clear that only mice reconstituted with both L3T4 + and Lyt-2+ T cell subpopulations rejected H-Y-disparate skin grafts . In a final experiment, H-2b female nude mice engrafted with B6 male grafts were initially reconstituted with isolated L3T4 + T cells (Fig . 6c) . As before, such mice failed to reject their grafts . On day 60 these mice were additionally given isolated Lyt-2+ T cells, and shortly thereafter, began rejecting their H-Y-disparate skin allografts (Fig . 6c) . In contrast, such mice not additionally given isolated Lyt-2+ T cells retained their H-Y-disparate skin grafts indefinitely (>300 d) . Thus, unlike the rejection of MHC class I and class II disparate skin allografts, the rejection of H-Y-disparate skin allografts required interactions between L3T4+ and Lyt-2+ T cells. Since Rejection responses of B10 bm1 normal mice engrafted with B6 .TIa' or (10) Kb-6 skin allografts . B10 normal mice were engrafted with B6, bml, bm6, or B6 .TIa' skin on day 0. Grafts were scored daily until rejection or day 60 . Number of mice in each group is indicated. Skin Allograft Rejection Resultingfrom Interactions Between T Cells with Different Antigen Specificities. In the course of our studies on skin allograft rejection, we encountered two situations in which normal B6 mice failed to reject allogeneic skin grafts (9, 41) . Thus, most B6 mice failed to reject either Qala or K`s kin allografts (Fig . 7) , indicating a deficiency in Qala-specific and Kbm6 -specific inducer T cell function, effector T cell function, or both . To examine whether an antigen-specific deficiency in inducer T cell function was the sole basis for the failure of normal 136 mice to reject these two types of skin allografts, we asked whether anti-Qala or anti-K"" effector cells were present in B6 mice and whether they could be activated in vivo by inducer T cells with a different antigen specificity to effect the rejection of Qala or Kbn,s skin allografts . Consequently, in the following experiments normal B6 mice were engrafted simultaneously with two skin grafts : (a) on the left flank, an inducer graft bearing both the target antigen (either Qala or Kbn'6) as well as additional helper determinants, In the first experiment of this type, we assessed the ability of Qala-specific effector cells to be activated by H-Y-specific Th cells to subsequently reject Qala skin allografts (Table III ) . In the absence of an inducer graft expressing putative helper determinants, B6 female mice failed to reject Qala disparate indicator grafts (group 1) . However, in the presence of an inducer graft expressing both Qala target antigens and H-Y helper determinants, B6 female mice rapidly rejected the indicator grafts expressing Qala alloantigens alone, and also rapidly rejected the inducer grafts (group 2) . This rejection of the Qala indicator grafts reflected the activation of Qala-specific effector cells and did not simply reflect crossreactive recognition of Qala alloantigens by H-Y-specific effector cells since most mice engrafted with inducer grafts expressing H-Y-antigens alone failed to reject the Qala indicator grafts (group 3) . Further, the activation of Qala-specific effector cells by Qala plus H-Y-expressing inducer grafts required activation of H-Y-specific T cells since such inducer grafts, when placed on B6 male mice that cannot recognize H-Y allodeterminants, failed to activate effector cells capable of rejecting the Qala indicator grafts (group 4) . This experiment demonstrates that B6 mice do contain Qala -specific effector cells and that such cells can interact with H-Y-specific T-inducer cells or their products to effect the rejection of Qaladisparate skin grafts .
In the second experiment of this type, we asked if Kb mfi -specific effector cells were present in B6 mice and whether they could collaborate with bm 12-specific T-inducer cells to effect the rejection of Kbmfi skin allografts ( -specific T-inducer cells since the L3T4+ Ibm12 -specific effector cells that rejected the inducer grafts were incapable of rejecting the Kbt»6 indicator grafts (group 6). Thus, the experiments in Table IV demonstrate The experiments summarized in Tables III and IV make two points . First, they demonstrate in normal mice that skin allograft rejection can be mediated by interactions between distinct subsets of T-inducer and T-effector cells, and that the interacting T cells need not recognize the same antigen specificities. And second, these experiments indicate that an inability to reject specific allografts can reflect a selective deficiency in antigen-specific Th/T-inducer cells .
Discussion
In the present study we used an adoptive transfer model to assess the phenotype, specificity, and functional capability of the T cells involved in initiating and mediating skin allograft rejection. The results of this study demonstrate that skin allograft rejection is neither unique to a specialized subset of T cells with a given Lyt phenotype, nor unique to a specialized subset of helper-independent effector T cells with so-called dual function capability . Rather, this study indicates that skin allograft rejection can be mediated by in vivo collaborations between Tinducer cells and T-effector cells, and that the two interacting T cell subsets can express different Lyt phenotypes as well as different antigen specificities. The present study also demonstrates that a selective deficiency in antigen-specific T- inducer cells results in a failure to reject specific skin allografts despite the presence of antigen-specific T-effector cells. The Lyt phenotype and antigen specificity of T cells that function as T-inducer and T-effector cells for in vivo allograft rejection responses parallel closely those of T cells that function as lymphokine-secreting Th and lymphokine-responsive Tk cells for in vitro cytolytic T cell responses. Indeed, in vivo skin allograft rejection was observed only in those mice whose T cell populations contained, by in vitro assessment, both Th and Tk cells reactive against the alloantigens of the graft. The experimental model system that we used involved the reconstitution of skin-engrafted B 10 nude mice with either whole spleen cell populations or negatively selected spleen cell subpopulations from naive H-2b mice . In theory, it was possible that reconstituted nude mice contained T cells derived either from the nude host animal (42) or from contaminants in the reconstituting T cell population . However, flow cytometry failed to detect significant numbers of mature (i .e ., L3T4' or Lyt-2+) T cells derived from any source other than that with which the experimental mice were reconstituted. Upon adoptive transfer, it was found that nude mice reconstituted with negatively selected populations of Lyt-2+ T cells rapidly rejected MHC class I-disparate skin allografts, whereas nude mice reconstituted with negatively selected populations of L3T4'' T cells rapidly rejected MHC class II-and minor H-disparate skin allografts . The simplest interpretation of these observations was that the rejection specificities expressed by adoptively transferred T cell populations merely reflected their antigen specificities (43) . However, such a perspective did not explain why collaboration between phenotypically distinct populations of L3T4' and Lyt-2' T cells was required for the rejection of H-Y-disparate skin allografts . Similarly, even though multiple minor H-disparate skin allografts were rejected by isolated L3T4 + T cell populations (Fig . 5, center) , their rejection by T cell populations containing both L3T4 + and Lyt-2+ cells was significantly more rapid (Fig . 5,  left) , indicating that cell interactions between phenotypically distinct T cell populations also enhanced the rejection of multiple minor H-disparate skin allografts .
Consequently, we thought that a better understanding of the roles performed by T cells in skin allograft rejection would result from the simultaneous consideration of their Lyt phenotype, recognition specificity, and functional capabilities (Table V) . Because cytolytic T cell responses have been considered to be the in vitro counterpart of in vivo graft rejection (44, 45) , the T cell functions we focused on were those involved in CTL responses, namely the stimulation of lymphokine-mediated T cell help and the activation of lymphokine-responsive Tk cells (15, 37) . The usefulness of such an analysis is evident in Table V; secreting lymphokines, we think it is highly likely that they do so, since given the recognition specificities of T-inducer and T-effector cells, they are unable to recognize each other directly . However, Dr . Kevin Lafferty (University of Colorado, Barbara Davis Center, Denver, CO, personal communication) has suggested the alternate possibility that activated macrophages, rather than soluble lymphokines, perform the intermediary role in vivo between Th/T-inducer cells and Tk/T-effector cells, such that Tk/T-effector cells are triggered only by interacting with macrophages that had previously interacted with Th/T-inducer cells. Since T-effector cells for skin allograft rejection in vivo and Tk cells for CTL responses in vitro are identical in their Lyt phenotypes, antigen specificities, and helper requirements, it is tempting to conclude that T-effector and Tk cells are also one and the same . Indeed, it has been previously shown (46) (47) (48) (49) that Tk cells are among the cellular elements that infiltrate rejecting allografts . Nevertheless, it is not yet clear that the mechanism by which T-effector cells reject skin allografts involves cell mediated cytolysis.
Consistent with the relationship between in vitro T cell responses and in vivo allograft rejection, the present in vivo demonstration of a selective Th cell deficiency in the failure of H-26 mice to reject Qal disparate skin allografts parallels in vitro observations of a Th cell deficiency in Qal-specific CTL responses (50, 51) . Moreover, the ability of H-Y to function as a helper determinant for the in vivo activation of anti-Qal T-effector cells to reject Qaldisparate skin allografts (Table III) also parallels the reported ability of H-Y to function as a helper determinant in vitro to activate anti-Qal Tk cells (50, 51) .
While this study indicates that skin allograft rejection occurs only in those mice containing both lymphokine-secreting Th and lymphokine-responsive Tk cells reactive against the alloantigens of the graft, it should be emphasized that the presence of both Th and Tk cells is not sufficient to predict that rejection will occur. For example, the majority of B6 mice fail to reject bm6 skin allografts despite the in vitro assessment that they contain both anti-K bms Th and Tk cells (Table V; reference 18) , and despite their ability to generate anti-K b,s CTL responses in vitro (18) . Indeed, the present demonstration that a selective Th cell deficiency is responsible for the failure of H-26 mice to reject bm6 skin allografts is consistent with our previous observations that H-26 mice contain anti-Kb-6 L3T4 + Th cells but are deficient in anti-Kb,6 Lyt-2+ Th cells (18) , and that it is the Lyt-2+ Th cell population that initiates the rejection of MHC class I-disparate skin allografts (9 (16, 19) . The present results strongly support previous conclusions (1, 5, 7, 48) that both help and cytolytic T cell functions, whether provided by a single dual function T cell or by interactions between two functionally distinct T cells are necessary to initiate and mediate skin allograft rejection. However, the present observation that Lyt-2+ ,L3T4-T cell populations are fully capable of rejecting skin allografts expressing MHC class I disparities appears to conflict with the observation of Cobbold and Waldmann (53) that in vivo administration of anti-L3T4 antibody significantly inhibited the rejection of fully allogeneic skin allografts . Studies investigating this apparent discrepancy are in progress .
In conclusion, the present study indicates that skin allograft rejection can be reasonably viewed as the in vivo endpoint of an antigen-specific immune process initiated by lymphokine-secreting Th cells and mediated by lymphokine responsive Tk cells. Thus, a rejection response depends upon: (a) the presence of Th and Tk cells each specific for alloantigens expressed by the graft, and (b) the ability of cellular elements within the skin allograft to fulfill the recognition and activation requirements of the allospecific T cell populations present in the host .
Summary
In the present study we used an adoptive transfer model with athymic nude mice to characterize the T cells involved in initiating and mediating skin allograft rejection . It was found that skin allograft rejection in nude mice required the transfer of immunocompetent T cells and that such reconstitution did not itself stimulate the appearance of T cells derived from the nude host . Reconstitution with isolated populations of Lyt-2'/L3T4-T cells resulted in the rapid rejection of MHC class I-disparate skin allografts, whereas reconstitution with isolated populations of L3T4'/Lyt-2-T cells resulted in the rapid rejection of MHC class I1-disparate and minor H-disparate skin allografts . By correlating these rejection responses with the functional capabilities of antigen-specific T cells contained within the reconstituting Lyt-2' and L3T4 + T cell populations, it was noted that skin allografts were only rejected by mice that, as shown by in vitro assessment, contained both lymphokine-secreting Th cells and lymphokine-responsive Tk cells specific for the alloantigens of the graft . The ability of two such functionally distinct T cell subsets to interact in vivo to reject skin allografts was directly demonstrated in H-Y-specific rejection responses by taking advantage of the fact that H-Y-specific Th cells are L3T4+ while H-Y specific Tk cells are Lyt-2' . Finally, the importance of in vivo interactions between functionally distinct Th/T-inducer cells and T killer (Tk)/T-effector cells in skin allograft rejection was demonstrated by the observation that normal B6 mice retain Qal' and Kb "'6 skin allografts because of a selective deficiency in antigen-specific Th cells, even though they contain T-effector cells that, when activated, are able to reject such allografts .
Thus, the ability to reject skin allografts is neither unique to a specialized subset of T cells with a given Lyt phenotype, nor unique to a specialized subset of helper-independent effector T cells with so-called dual function capability . Rather, skin allograft rejection can be mediated by in vivo collaborations between T-inducer cells and T-effector cells, and the two interacting T cell subsets can express different Lyt phenotypes as well as different antigen specificities .
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